Lanthionine Synthetase C-Like 2 Modulates Immune Responses to Influenza Virus Infection

Broad-based, host-targeted therapeutics have the potential to ameliorate viral infections without inducing antiviral resistance. We identified lanthionine synthetase C-like 2 (LANCL2) as a new therapeutic target for immunoinflammatory diseases. To examine the therapeutic efficacy of oral NSC61610 ad...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Immunol
Hlavní autoři: Leber, Andrew, Bassaganya-Riera, Josep, Tubau-Juni, Nuria, Zoccoli-Rodriguez, Victoria, Lu, Pinyi, Godfrey, Victoria, Kale, Shiv, Hontecillas, Raquel
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2017
Témata:
Immunology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5318425/
https://ncbi.nlm.nih.gov/pubmed/28270815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2017.00178
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky